These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2457561)

  • 21. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
    van Crugten J; Bochner F; Keal J; Somogyi A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):481-7. PubMed ID: 3944769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cimetidine inhibits renal procainamide clearance.
    Christian CD; Meredith CG; Speeg KV
    Clin Pharmacol Ther; 1984 Aug; 36(2):221-7. PubMed ID: 6204803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration.
    Ellis EJ; Ravis WR; Malloy M; Duran SH; Smyth BG
    J Vet Pharmacol Ther; 1994 Aug; 17(4):265-70. PubMed ID: 7525982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
    Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
    J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen with that into the peritoneal cavity in rats.
    Arimori K; Hashimoto Y; Nakano M
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2050-2. PubMed ID: 1702691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procainamide-cimetidine drug interaction in elderly male patients.
    Bauer LA; Black D; Gensler A
    J Am Geriatr Soc; 1990 Apr; 38(4):467-9. PubMed ID: 2329253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F; Alballa RS; Mehvar R; Lemko CH
    Ther Drug Monit; 1988; 10(1):91-6. PubMed ID: 2453956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined pharmacokinetic-pharmacodynamic model of procainamide in rabbits with induced ventricular fibrillation threshold (VFT) changes].
    Lu H; Huang SK; Yang JY; Lu DY; Lu JF
    Yao Xue Xue Bao; 1991; 26(7):481-7. PubMed ID: 1725230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance.
    Hardy BG; Schentag JJ
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):388-91. PubMed ID: 3220613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimetidine reduces procainamide elimination.
    Somogyi A; Heinzow B
    N Engl J Med; 1982 Oct; 307(17):1080. PubMed ID: 6181402
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA; Coyle JD
    Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of cimetidine coadministration on the pharmacokinetics of sotalol enantiomers in an anaesthetized rat model: evidence supporting active renal excretion of sotalol.
    Carr RA; Pasutto FM; Foster RT
    Biopharm Drug Dispos; 1996 Jan; 17(1):55-69. PubMed ID: 8991491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin.
    Desager JP; Harvengt C; Bianchetti G; Rosenzweig P
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):568-71. PubMed ID: 7904983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the autonomic effects of procainamide and N-acetylprocainamide in the dog.
    Reynolds RD; Gorczynski RJ
    J Pharmacol Exp Ther; 1980 Mar; 212(3):579-83. PubMed ID: 6153717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ; Ruo TI
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.